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Key questions
What is already known about this subject?
Myocardial ischaemia in non-obstructive coronary 
artery disease (INOCA) have a multifactorial aetiology 
and is associated with an impaired prognosis.
What does this study add?
Higher aortic stiffness assessed by carotid-femoral 
pulse wave velocity is independently associated with 
INOCA.
How might this impact on clinical practice?
Assessment of aortic stiffness may add to the 
diagnostic evaluation of patients with stable angina 
and non-obstructive coronary arteries and may 
facilitate individualised treatment.
AbstrAct
Objective High aortic stiffness may reduce myocardial 
perfusion pressure and contribute to development of 
myocardial ischaemia. Whether high aortic stiffness is 
associated with myocardial ischaemia in patients with 
stable angina and non-obstructive coronary artery disease 
(CAD) is less explored.
Methods Aortic stiffness was assessed as carotid-femoral 
pulse wave velocity (PWV) by applanation tonometry in 
125 patients (62±8 years, 58% women) with stable angina 
and non-obstructive CAD participating in the Myocardial 
Ischemia in Non-obstructive CAD project. PWV in the 
highest tertile (>8.7 m/s) was taken as higher aortic 
stiffness. Stress-induced myocardial ischaemia was 
detected as delayed myocardial contrast replenishment 
during stress echocardiography, and the number of 
left ventricular (LV) segments with delayed contrast 
replenishment as the extent of ischaemia.
Results Patients with higher aortic stiffness were older 
with higher LV mass index and lower prevalence of obesity 
(all p<0.05), while angina symptoms, sex, prevalence of 
hypertension, diabetes, smoking or LV ejection fraction 
did not differ between groups. Stress-induced myocardial 
ischaemia was more common (73% vs 42%, p=0.001) 
and the extent of ischaemia was larger (4±3 vs 2±3 LV 
segments, p=0.005) in patients with higher aortic 
stiffness. In multivariable logistic regression analysis, 
higher aortic stiffness was associated with stress-induced 
myocardial ischaemia independent of other known 
covariables (OR 4.74 (95% CI 1.51 to 14.93), p=0.008).
Conclusions In patients with stable angina and non-
obstructive CAD, higher aortic stiffness was associated 
with stress-induced myocardial ischaemia. Consequently, 
assessment of aortic stiffness may add to the diagnostic 
evaluation in patients with non-obstructive CAD.
Trial registration number NCT01853527.
InTROduCTIOn
Ischaemia in non-obstructive coronary artery 
disease (INOCA), characterised by myocar-
dial ischaemia without flow-limiting stenosis 
by coronary angiography, is a common 
finding, particularly in women, and associ-
ated with an impaired prognosis.1 2 The Coro-
nary CT Angiography EvaluatioN For Clin-
ical Outcomes: An InteRnational Multicenter 
registry reported a prevalence of non-ob-
structive coronary artery disease (CAD) of 
30% and a twofold increase in 5-year cardi-
ovascular morbidity and mortality.3 A recent 
consensus document underlines the multifac-
torial aetiology and the lack of scientifically 
funded recommendations for management 
of INOCA.4 Thus, better diagnostic algo-
rithms and evidence-based risk assessment 
tools are needed for management of patients 
with INOCA.5–7
Aortic stiffness, assessed non-invasively as 
pulse wave velocity (PWV), is an established 
risk predictor in hypertension8 and in an 
urban female population.9 Increased aortic 
stiffness is also a predictor of presence, severity 
and prognosis of CAD in both general and 
high-risk populations.10–14 Increased aortic 
stiffness is associated with increased systolic 
and reduced diastolic blood pressure (BP) 
in the aortic root due to earlier return of 
the reflectory pressure waves from the distal 
aorta.15 This leads to increased left ventric-
ular (LV) afterload and oxygen demand, 
reduced myocardial diastolic perfusion 
pressure and consequently myocardial isch-
aemia.16 17 Thus, in a previous study of asymp-
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aortic stiffness was associated with myocardial perfusion 
defects by single-photon emission computed tomography 
(SPECT) imaging.18
Whether increased aortic stiffness measured by PWV is 
associated with INOCA is less explored. Accordingly, we 
assessed the association between higher aortic stiffness 
and stress-induced myocardial ischaemia in patients with 
angina and non-obstructive CAD.
MeTHOds
Patient population
The current analysis was prospectively planned within the 
Myocardial Ischemia in Non-obstructive Coronary Artery 
Disease project, a cross-sectional observational study that 
included 132 patients with stable angina and non-ob-
structive CAD by coronary CT angiography. Inclusion 
criteria were stable angina for at least 6 months, presence 
of non-obstructive CAD by coronary CT angiography, age 
>30 years and presence of at least one cardiovascular risk 
factor. Exclusion criteria were significant coronary artery 
stenosis (lumen diameter reduction ≥50%) or normal 
coronary CT angiography, as well as clinically unstable 
angina, severe valve disease, mechanical valve prosthesis, 
arrhythmias, severe pulmonary disease or known allergies 
to ultrasound contrast. Carotid femoral PWV could not 
be measured in seven patients due to cardiac arrhythmias 
(atrial fibrillation or frequent premature extra beats), 
and these were excluded leaving 125 patients for the 
present analysis. Written informed consent was obtained 
from all study participants.
Cardiovascular risk factor assessment
All study participants reported cardiovascular risk factors, 
medical history and medication on a standardised ques-
tionnaire. Clinical examination and collection of fasting 
blood samples were performed in all. BP was measured 
three times in the sitting position following the European 
Society of Hypertension guidelines using a digital auto-
matic sphygmomanometer Omron M4 (Omron Health-
care Co, Hoofddorp, the Netherlands), and the office 
BP was taken as the mean of the two last measurements.8 
Hypertension was defined as known hypertension, use of 
antihypertensive drugs or office systolic BP ≥140 mm Hg 
and/or diastolic BP ≥90 mm Hg. Diabetes was defined as 
known diabetes or use of antidiabetic drugs. Hypercholes-
terolaemia was defined as total cholesterol >6.5 mmol/L 
or on statin treatment. Body mass index (BMI) was calcu-
lated as body weight in kilograms divided by height in 
metres squared. Obesity was defined as BMI ≥30 kg/m2.
Carotid-femoral PWV
Carotid-femoral PWV was measured by applanation 
tonometry using the SphygmoCor device (AtCor, 
Medical, Sydney, West Ryde, Australia) by an experienced 
operator (MVK). Following current recommendations, 
pressure pulse waveforms from the right common carotid 
and femoral arteries were obtained transcutaneously, and 
the PWV was calculated as the transit time between the 
two arterial sites, determined in relation to the R-wave of 
the ECG and divided by the net distance between the two 
recording sites.15 PWV in the highest population tertile 
(>8.7 m/s) was regarded as higher aortic stiffness.
echocardiography
Conventional echocardiography was performed on a 
Philips ie33 (Philips Medical Systems) scanner following 
a standardised protocol. All echocardiograms were read 
offline on a workstation equipped with Image Arena 
software version 4.1 (TomTec Imaging Systems GmbH, 
Unterschleissheim, Germany) by the same experienced 
reader (MTL). Measurements were made according to 
the joint American Society of Echocardiography/Euro-
pean Association of Cardiovascular Imaging recommen-
dations.19 LV mass was calculated by Devereux’s equation 
and indexed for height in metres in the allometric power 
of 2.7. LV hypertrophy was defined by the prognostically 
validated cut-off values of LV mass index >46.7 g/m2.7 in 
women and >49.2 g/m2.7 in men.20 Relative wall thick-
ness was calculated as 2× posterior wall thickness/LV 
internal radius ratio. LV filling was assessed by the ratio 
between transmitral flow (E-wave) and mitral annular 
velocity (e′).
Myocardial contrast echocardiography was performed 
with real-time low-mechanical index imaging and 
destruction replenishment following current guide-
lines.21 22 Ultrasound contrast agent (SonoVue, Bracco, 
Milan, Italy) was administered intravenously as 1 mL 
bolus followed by continuous infusion of 1 mL/hour 
using a rotating infusion pump (VueJet, Bracco, Milan, 
Italy). Myocardial perfusion was visually scored as normal 
or abnormal in the individual 17-segments of the LV 
using the apical 2-chamber, 3-chamber and 4-chamber 
views at rest and at peak dobutamine stress.19 Stress-in-
duced myocardial ischaemia was defined as presence 
of delayed contrast replenishment two heartbeats after 
flash at peak stress in any LV segment. The number of LV 
segments with delayed perfusion at peak stress was taken 
as a measure of the extent of myocardial ischaemia.
Coronary CT angiography
Prior to inclusion into the study, all patients had under-
gone coronary CT angiography by a 256-slice dual 
source CT scanner (Somatom Definition Flash, Siemens, 
Germany) with ECG triggered acquisition and intrave-
nously iomeprol 400 mg I/mL contrast (Iomeron, Bracco, 
Milan, Italy). Coronary artery calcium score and degree 
of coronary artery stenosis were assessed by experienced 
readers following a modified 20-segment American Heart 
Association model.23 High coronary artery calcium score 
was defined as a calcium score >100 Hounsfield units 
(HU). Non-obstructive CAD was defined as a lumen 
diameter reduction of 1%–49% in any coronary artery 
segment without any segments with ≥50% lumen diam-
eter reduction and extent of non-obstructive CAD are 
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Age (years) 60±9 67±6 <0.001
Female sex (%) 63 49 0.127
BMI (kg/m2) 28.0±4.9 27.1±3.8 0.268
Waist circumference (cm) 97±13 98±10 0.636
Obesity (%) 29 12 0.042
Chest pain (%) 79 71 0.335
Exertional dyspnoea (%) 63 68 0.568
Heart rate (BPM) 69±12 66±11 0.197
Systolic blood pressure 
(mm Hg)
130±14 143±18 <0.001
Diastolic blood pressure 
(mm Hg)
76±12 82±14 0.018
Hypertension (%) 70 83 0.118




Family history of 
premature CAD (%)
68 44 0.018




Previous stroke (%) 1 11 0.017
Known peripheral artery 
disease (%)
3 14 0.016








Serum HDL (mmol/L) 1.5±0.5 1.5±0.4 0.751







BMI, body mass index;CAD, coronary artery disease;GFR, 
glomerular filtration rate;HDL, High Density Lipoprotein;LDL, Low 
Density Lipoprotein;PWV, pulse wave velocity.
statistical analysis
Data management and analysis were performed using 
IBM SPSS Statistics V.24 (IBM Corporation, Armonk, 
New York, USA). Patients were grouped in tertiles 
of PWV, and the highest tertile (PWV >8.7 m/s) was 
regarded as high aortic stiffness. Patients with high 
aortic stiffness were compared with patients with normal 
aortic stiffness by unpaired Student’s t-test and χ statis-
tics as appropriate. Results are presented as mean±SD 
for continuous variables and percentages for categorical 
variables. The performance of PWV and calcium-score to 
detect stress-induced myocardial ischaemia is expressed 
and compared using receiver operating characteristics 
(ROC) curve and the area under the curve (AUC) with 
95% CI. The association between higher aortic stiffness 
and stress-induced myocardial ischaemia was explored in 
univariable and multivariable logistic regression analysis, 
adjusting for known confounders and presented as OR 
with 95% CI. To further adjust for bias, propensity score 
matching for age, sex, systolic BP, hypertension, diabetes, 
smoking, hypercholesterolaemia, obesity, LV mass index, 
LV filling, calcium score and segment involvement score 
by coronary CT angiography was performed between 
cases with and without ischaemia. A two-tailed p value 
<0.05 was regarded as significant.
ResulTs
Patients’ characteristics
Patients with high aortic stiffness were older and had 
higher BP, higher prevalence of hypercholesterolaemia 
and lower prevalence of obesity and familial premature 
CAD (all p<0.05), while there were no differences in sex, 
angina symptoms, prevalence of hypertension, diabetes, 
smoking or renal function (table 1). In patients with high 
aortic stiffness, a history of stroke and known peripheral 
artery disease was more common, and more patients 
used antiplatelet and statin treatment, while there were 
no differences in antihypertensive treatment between 
groups (table 1).
Aortic stiffness and myocardial ischaemia
Stress-induced myocardial ischaemia was more prevalent, 
and the extent of ischaemia was larger among patients 
with high aortic stiffness, while there was no difference 
in coronary artery calcium score or segment involvement 
score by coronary CT angiography (table 2). LV mass 
index and LV filling was higher, but there were no signifi-
cant difference in left atrial volume, LV ejection fraction, 
prevalence of hypertrophy and concentric LV geometry 
(table 2).
In univariable analysis, high aortic stiffness was asso-
ciated with presence of stress-induced myocardial isch-
aemia (OR 3.82 (95% CI 1.69 to 8.62), p=0.001). In 
multivariable logistic regression analysis, higher aortic 
stiffness remained significantly associated with presence 
of stress-induced myocardial ischaemia independent of 
age, systolic BP, hypercholesterolaemia, obesity, LV mass 
index, LV filling, as well as calcium score and segment 
involvement score by coronary CT angiography (table 3). 
After adding propensity score matching between cases 
with and without myocardial ischaemia accounting for 
known covariables, aortic stiffness remained signifi-
cantly associated with myocardial ischaemia, (OR 5.01, 
p=0.011).
In ROC curve analysis, PWV was a better predictor of 
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Table 2 Cardiovascular imaging characteristics
Lower PWV Higher PWV P value
PWV (m/s) 7.4±0.9 10.9±2.4
Coronary CT angiography
Coronary artery calcium score (HU) 71±100 107±133 0.138
High calcium score (%) 22 36 0.104
Segment involvement score 2±1 3±1 0.297
Echocardiography
Left atrium biplane volume (mL/m2) 42±12 45±17 0.329
Intraventricular septum in diastole (cm) 1.1±0.2 1.2±0.2 0.013
LV end-diastolic dimension (cm) 4.5±0.5 4.5±0.6 0.994
LV end-systolic dimension (cm) 2.9±5.0 2.9±6.1 0.616
Posterior wall thickness in diastole (cm) 0.9±0.2 1.0±0.2 0.042
LV ejection fraction (%) 62±6 62±9 0.704
LV mass index (g/m2.7) 38.5±8.2 42.5±10.8 0.042
Relative wall thickness 0.40±0.09 0.44±0.13 0.074
LV hypertrophy (%) 14 22 0.282
Concentric geometry (%) 29 42 0.149
Isovolumic relaxation time (ms) 79±18 84±15 0.104
LV filling 9.5±2.2 10.7±3.2 0.042
Myocardial contrast stress echocardiography
Stress-induced myocardial ischaemia (%) 42 73 0.001
Number of LV segments with ischaemia 2±3 4±3 0.002
LV, left ventricular;PWV, pulse wave velocity.
Table 3 Covariables of higher aortic stiffness in patients with angina and non-obstructive CAD in multivariable logistic 
regression analysis
Variables Univariable Multivariable
OR 95% CI P value OR 95% CI P value
Myocardial ischaemia 3.81 1.69 to 8.62 0.001 4.74 1.51 to 14.93 0.008
Age (years) 1.14 1.07 to 1.22 <0.001 1.12 1.04 to 1.22 0.005
Systolic BP (mm Hg) 1.05 1.03 to 1.08 <0.001 1.06 1.02 to 1.10 0.001
Hypercholesterolaemia 2.30 1.07 to 4.93 0.33 3.04 1.03 to 9.01 0.045
Obesity 2.88 1.01 to 8.22 0.048 1.58 0.41 to 6.22 0.508
LV mass index (g/m2.7) 1.05 1.01 to 1.09 0.028 1.03 0.98 to 1.09 0.282
LV filling 1.19 1.02 to 1.38 0.024 1.00 0.81 to 1.24 0.981
Calcium score 1.00 0.99 to 1.01 0.110 1.00 0.99 to 1.01 0.903
Segment involvement score 1.15 0.88 to 1.49 0.307 1.18 0.79 to 1.78 0.420
BP, blood pressure;CAD, coronary artery disease; LV, left ventricle.
CI 0.55 to 0.75), p=0.005) than coronary artery calcium 
score by coronary CT angiography (figure 1).
dIsCussIOn
This study demonstrates for the first time the association 
of higher PWV with stress-induced myocardial ischaemia 
in patients with INOCA, suggesting that higher aortic 
stiffness may contribute to reduced myocardial perfusion 
during stress in such patients.
Aortic stiffness is an established risk predictor in hyper-
tension8 and associated with increased cardiovascular 
events and all-cause mortality rate in both hypertensive 
and general populations.12 14 The prognostic value of 
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Figure 1 ROC curve analysis for pulse wave velocity and coronary artery calcium score in assessment of myocardial 
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with ST-elevation myocardial infarction.24 Experimental 
and clinical studies have suggested that aortic stiffening 
leads to reduced coronary flow and subendocardial isch-
aemia even in the absence of coronary artery stenosis.25 26 
The characteristic early return of the pulse wave reflec-
tions to the aortic root in aortic stiffness increases the 
systolic BP and the workload of the LV, thereby increasing 
the myocardial oxygen demand and lowering the isch-
aemic threshold in the myocardium.15 In addition, the 
early pulse wave reflections in aortic stiffness reduces 
the diastolic perfusion pressure in the myocardium and 
causes a reduction in coronary artery flow. The duration 
of the diastole is also reduced due to the increased LV 
after load, further amplifying the reduction in myocar-
dial blood flow.15 Theoretically, these pathophysiological 
changes in combination with increased atheromatosis 
associated with aortic stiffness will contribute to devel-
opment of myocardial ischaemia in patients with higher 
PWV, as demonstrated in the present study.
The Women’s Ischemia Syndrome Evaluation study 
demonstrated that myocardial ischaemia may be present 
in non-obstructive CAD and that myocardial ischaemia 
in patients with non-obstructive CAD was associated with 
an impaired prognosis.27 28 Recently, INOCA, the clinical 
syndrome of myocardial ischaemia in non-obstructive 
CAD, has been recognised as a diagnostic and thera-
peutic challenge.1 In the present study, stress-induced 
myocardial ischaemia was identified in 52% of patients 
with symptomatic angina and non-obstructive CAD, 
pointing to the need for additional non-invasive cardio-
vascular imaging to identify patients with INOCA even in 
the presence of angina. Furthermore, our results add to 
current knowledge by demonstrating that higher PWV 
was closer associated with stress-induced myocardial isch-
aemia in non-obstructive CAD then calcium score and 
segment involvement score by coronary CT angiography. 
This suggest assessment of PWV may identify patients 
with symptomatic non-obstructive CAD with a high likeli-
hood for stress-induced myocardial ischaemia.
Advances in anatomical and functional imaging may 
contribute to improvement in the diagnostic and prog-
nostic evaluation in INOCA. Myocardial ischaemia in 
non-obstructive CAD has a multifactorial aetiology,6 
including microvascular and endothelial dysfunction. We 
have previously demonstrated the association between LV 
hypertrophy and myocardial ischaemia in hypertensive 
heart disease.29 Of note, though both LV hypertrophy 
and aortic stiffness are regarded as hypertension-me-
diated target organ damage, high aortic stiffness was 
associated with stress-induced myocardial ischaemia inde-
pendent of BP and LV mass index in the multivariable 
analysis. Interestingly, coronary artery calcium score was 
not associated with myocardial ischaemia in the present 
study, in line with previous studies demonstrating that 
non-calcified hypodense coronary artery plaques carries 
the highest cardiovascular risk.30 In addition, as also 
demonstrated in our study, both PWV and prevalence 
of myocardial ischaemia increases with age. A previous 
study have established normal reference values for PWV 
in different age and BP categories based on a large Euro-
pean population.31 However, among patients with angina 
and non-obstructive CAD, higher PWV was associated 
with myocardial ischaemia independent of age, and the 
association remained significant even after propensity 
score matching for major confounders including age.
In clinical practice, there is a lack of scientifically 
based recommendations for management of angina with 
non-obstructive CAD, including systematic assessment of 
stress-induced myocardial ischaemia. Considering the 
multifactorial aetiology of myocardial ischaemia in such 
patients, the need for an accurate diagnosis and individ-
ualised treatment is emphasised by the impact of myocar-
dial ischaemia on quality of life and prognosis.4 5
study limitations
This is a small study including 125 patients increasing the 
risk of type 2 statistical errors. Since this is a cross-sec-
tional study, no causal mechanisms can be identified. 
Furthermore, the study included only patients with cardi-
ovascular risk factors clinically referred for coronary CT 
angiography, introducing a possible selection bias. The 
results should therefore be generalised to less selective 
populations with caution. However, our study adds to 
current knowledge by demonstrating that higher PWV is 
associated with an increased risk for presence of INOCA, 
underlining the need for larger follow-up studies to 
further evaluate the role in diagnosis and risk stratifica-
tion of aortic stiffness assessment by PWV in patients with 
angina and non-obstructive CAD.
COnClusIOn
In patients with stable angina and non-obstructive CAD 
by coronary CT angiography, higher aortic stiffness was 
associated with stress-induced myocardial ischaemia. This 
suggests that assessment of aortic stiffness may add to the 
diagnostic evaluation in patients with non-obstructive 
CAD. However, further research is needed to evaluate 
if assessment of aortic stiffness can become a diagnostic 
and risk stratification tool in non-obstructive CAD.
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